Granulocyte Colony-Stimulating Factor Potentiated Severe Atypical Vincristine-Induced Neuropathy
Author(s) -
Soad Al-Bahar,
Ramesh Pandita,
Bipin N. Savani,
Ketan G. Bavishi
Publication year - 1998
Publication title -
medical principles and practice
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.426
H-Index - 45
eISSN - 1423-0151
pISSN - 1011-7571
DOI - 10.1159/000026024
Subject(s) - medicine , vincristine , granulocyte colony stimulating factor , neuropathic pain , concomitant , peripheral neuropathy , anesthesia , weakness , surgery , chemotherapy , endocrinology , cyclophosphamide , diabetes mellitus
We report a patient with acute lymphoblastic leukemia who developed severe atypical neuropathy (SAN), distinct from classical vincristine neuropathy, following the use of vincristine and granulocyte colony-stimulating factor (G-CSF). SAN was characterized by acute onset of severe pain, exquisite tenderness on even light touch and profound motor weakness involving predominantly the lower limbs. The upper limbs were spared. Imaging studies and cerebrospinal fluid examination were normal. Electrophysiological studies showed axonal sensorimotor neuropathy. Potentiation of vincristine-induced neuropathy by G-CSF should be considered when formulating protocols using both these agents, and concomitant use of both the agents should be avoided.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom